Lilly's triple agonist retatrutide posts its strongest weight loss numbers yet, setting up a 2027 FDA filing Eli Lilly, this week, reported positive topline results from TRIUMPH-2 and TRIUMPH-3, two pivotal Phase 3 trials of retatrutide, a once-weekly injectable that activates receptors for GIP, GLP-1, and glucagon simultaneously a triple mechanism that no approved obesity therapy currently matches
Two large epidemiological studies found an inverse correlation between selenium levels and thyroid function metrics in mildly iodine deficient women (89, 90)
Role of Astrocytes in Maintaining Cerebral Glutathione Homeostasis and in Protecting the Brain Against Xenobiotics and Oxidative Stress Arthur Cooper 6
Anti-inflammatory drugs such as high-dose aspirin, indomethacin (Cyclooxygenase inhibitors) Certain blood pressure and neurological medications, including clonidine and levodopa discuss with your provider (Somatostatin-containing medicines) Other Supplements Growth Hormone Boosters: Supplements such as arginine, GABA, and melatonin are sometimes used to raise growth hormone levels
